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Abstract
The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione
and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the
structural information of TryS from Leishmania major has become available. Unfortunately, the TryS structure was solved
without any of the substrates and lacks loop regions that are mechanistically important. This contribution describes docking
and molecular dynamics simulations that led to further insights into trypanothione biosynthesis and, in particular, explains
the binding modes of substrates for the second catalytic step. The structural model essentially confirm previously proposed
binding sites for glutathione, ATP and two Mg2+ ions, which appear identical for both catalytic steps. The analysis of an
unsolved loop region near the proposed spermidine binding site revealed a new pocket that was demonstrated to bind
glutathionylspermidine in an inverted orientation. For the second step of trypanothione synthesis glutathionylspermidine is
bound in a way that preferentially allows N1-glutathionylation of N8-glutathionylspermidine, classifying N8-glutathionyl-
spermidine as the favoured substrate. By inhibitor docking, the binding site for N8-glutathionylspermidine was characterised
as druggable.
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Introduction
The protozoan parasites of the genera Trypanosoma and
Leishmania cause neglected diseases such as Chagas’ disease,
African sleeping sickness or the various forms of Leishmaniasis,
which in toto still account for about 100 000 fatalities per annum [1]
(http://www.who.int/mediacentre/factsheets/fs259/en/index.
html). Current treatments of these diseases are unsatisfactory and
the lack of economic incentives is still hampering the development
of new drugs by the pharmaceutical industry [2,3]. However,
increasing understanding of the parasites’ biology, related genome
analyses and drug design technologies have more recently revived
the search for efficacious and safe trypanocidal drugs [4,5]. The
preferred strategy consists in the identification of metabolic
pathways that are essential for parasite survival and absent or
sufficiently different in their mammalian hosts to enable selective
inhibition of suitable molecular targets. An attractive example is
the trypanothione system which is only found in trypanosomes and
other Kinetoplastida [6], but not in any mammalian species [7].
In trypanosomatids, trypanothione [T(SH)2; N
1,N8-bis(glu-
tathionyl)spermidine] is the key redox metabolite that directly or
indirectly provides the reduction equivalents for multiple pathways
that in mammals depend on glutathione (GSH) or thioredoxins. In
fact, the only enzymes that efficiently use GSH in trypanosomatids
appear to be glutathionylspermidine synthetase (GspS) and
trypanothione synthetase (TryS). As first discovered in Crithidia
fasciculate [8], T(SH)2 is the proximal reductant for thioredoxin-
related proteins called tryparedoxins, which in turn reduce a
variety of tryparedoxin peroxidases, which may belong to the
peroxiredoxin or the glutathione peroxidase family (reviewed in
[9]), the ribonucleotide reductase [10] and proteins implicated in
proliferative control [11]. Without the aid of tryparedoxin, T(SH)2
substitutes for GSH in S-transferase reactions and regenerates
ascorbate as substrate for heme peroxidases in T. cruzi and
Leishmania species. Most of the enzymes constituting this system
have been demonstrated to be essential [12–15]. TryS, considering
its low cellular abundance, uniqueness of sequence [16], drugg-
ability [13,17,18] and dominant role in trypanosomatid redox
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metabolism, is accepted as a most attractive molecular target to
search for trypanocidal drugs [7,17].
We therefore reasoned that molecular modelling and docking
combined with molecular dynamics simulations might be the
approaches of choice to further clarify the mode of substrate
binding and mechanistic details of TryS. Here we present LmTryS
models which in essence confirm the presumed binding sites for all
substrates and, in particular, reveal how the intermediate Gsp
moves from the site of its formation into a position suitable for its
glutathionylation. Moreover, the Gsp binding site is here
characterized as druggable.
TryS is an unusual enzyme. It not only catalyses the synthesis of
T(SH)2, but also its breakdown; the latter activity residing in a
distinct domain [19]. But also the mechanism of T(SH)2 synthesis
itself has for long remained enigmatic. Initially thought to require
two distinct enzymes, GspS and TryS [20], TryS proved to be
competent and sufficient to catalyse both steps of T(SH)2 synthesis
[16,21,22]. This implies that GSH has to be conjugated to both of
the rather remote terminal amino groups of spermidine (Sp) by a
single enzyme (Fig. 1), which mechanistically is not easily
understood. As discussed by Comini et al. [16], i) two distinct
reaction centres could add GSH to N1 and N8 of Sp, ii) a single
reaction centre could be flexible enough to carry the activated
GSH to either of the Sp amino groups or iii) the intermediate Gsp
has to change its binding mode to offer the second amino group
for glutathionylation. With the structural elucidation of TryS of L.
major (LmTryS) by Fyfe et al. [19], the first possibility could be
ruled out: The synthesis domain only contains a single binding site
for ATP. The latter, like that of EcGspS [23] and other ligases,
displayed a typical ATP grasp fold into which ATP and two Mg2+
ions could be accommodated, although the loop presumed to
firmly keep the ATP in place (residues 552 to 578) was not visible
[19]. Further, a characteristic cleft to accommodate GSH in a way
that its glycyl carboxylate could be phosphorylated was detected,
while the putative Sp binding site appeared less structured. The
triangular arrangement of these three putative binding sites
appeared rather rigid and, in consequence, Fyfe et al. proposed
a re-location of the intermediate Gsp as the only left alternative to
synthesize T(SH)2. Unfortunately, however, the region where Gsp
was supposed to bind (residues 251 to 261) also turned out to be
disordered in the crystallographic analysis [19].
Materials and Methods
TryS Model Creation
During this computational analysis, four different TryS-models
of increasing complexity were created and subjected to molecular
dynamics simulations.
The first LmTryS model contains ADP and a Gsp analogue in
which the carboxamide group that links GSH to spermidine is
replaced by a phosphorylated phosphinate (see below, Fig. 2C). It
is based on a crystal structure (pdb: 2ioa) of E. coli glutathionyl-
spermidine synthetase (EcGspS) [23] that contains these ligands.
LmTryS and EcGspS have a sequence identity of ,30% [19], and
a structural overlay of the Ca-atoms of both synthetase domains is
possible with an rmsd of 1.54 A˚19. The synthetase domains of the
enzymes were superposed by MOE [24] (see Figure S1 in
Supporting Information S1 section I) and the Gsp analogue, ADP
and both Mg2+ ions were transferred from the EcGspS structure
into the LmTryS model and subjected to energy minimisation by
the pertinent MOE function and MFF94x force field with
relaxation of surrounding residues. Missing loop regions were
added using the MOE’s homology modelling module. The best
scored model (based on electrostatic solvation energy [25]) with
Figure 1. Two-step synthesis of trypanothione. For both steps, GSH has first to be activated by phosphorylation. Due to the asymmetry of
spermidine the first step of the trypanothione biosynthesis could lead to two different glutathionylspermidines.
doi:10.1371/journal.pone.0056788.g001
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both loop regions was used as starting conformation for molecular
dynamics simulation.
The second LmTryS model is based on a EcGspS crystal
structure (pdb: 2io7) that contains the ATP-analogue AMPPNP,
thus indicating the position of the c-phosphate of ATP [19]. After
superposition as before, AMPPNP and the Mg2+ ions were
transferred into the empty TryS crystal structure (pdb: 2vps).
AMPPNP was modified into ATP by replacing NH by O. GSH
was docked by GOLD [26] into its putative binding region
corroborated by the MD simulation performed on model 1.
Missing loop regions were added as above. The resulting model
was subjected to MD simulation.
For the final models, i. e. those with all substrates bound, protein
conformations from the previous MD simulation were used. A
Figure 2. Binding modes of a Gsp homologue. Two major conformations of the spermidine moiety of the Gsp analogue (C) are observed. In the
binding mode A loss of hydrogen bonds (orange dotted lines.) to Glu407 suggests weaker binding than in binding mode B.
doi:10.1371/journal.pone.0056788.g002
Figure 3. Structure and sequence comparison of the EcGspS crystal structure (pdb: 2ioa; A) and the modeled LmTryS structure (B).
Both structures contain ADP, the Gsp analogue (shown as sticks with carbons in yellow) and two Mg2+ ions (green balls). The yellow circle highlights
an additional pocket in the TryS model which results from sequence differences (C). The green surfaces (I and II) indicate flexible loop regions that
were not visible in the LmTryS crystal structure (pdb:2vps): In the EcGspS structure (A) region I (Gly 242 to Pro 249) does not offer any additional
binding site near the spermidine moiety of the Gsp analogue, while in the LmTryS model (B) the corresponding loop (Gly250 to 262; marked red in C)
builds part of the additional binding pocket. II shows the borders of the ATP Grasp fold loop (Pro534 to Gln563 in EcGspS and Val551to Asn579 in
LmTryS, respectively). The loop was removed in both structures to demonstrate the positions of ADP and Mg2+.
doi:10.1371/journal.pone.0056788.g003
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hierarchical clustering of the different protein conformations
shows 5 clusters (see Figures S9 and S10 in Supporting
Information S1 section III). Using the ensemble docking feature
of Gold 5.0, both glutathionylspermidine molecules (N1-Gsp and
N8-Gsp, see Fig. 1) were simultaneously docked into representative
conformations of these clusters to identify the best combination.
For the final models, the best scoring poses were used.
Figure 4. Atomic distances within the ‘new’ binding pocket of LmTryS. Minimum (min) and maximum (max) distances with mean and
standard deviations (sd) between Glu614 and Pro626 of the rigid part of the pocket and certain residues of the flexible loop region are given in A˚.
doi:10.1371/journal.pone.0056788.g004
Figure 5. Presumed substrate binding sites of LmTryS as derived from the model with bound ADP/Mg2+ and the Gsp analogue. ATP
is assumed to essentially occupy the position of ADP. The position of the ATP c-phosphate is mimicked by the phosphoryl group of the Gsp
analogue. The red line marks the binding site of GSH, the green line that of spermidine. The empty pocket surrounded by a magenta line can harber
the glutathionyl moiety of Gsp and, together with the spermidine binding site, thus could form a Gsp binding site.
doi:10.1371/journal.pone.0056788.g005
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Docking and Scoring
For docking GOLD 5.0 was used with standard settings and
Goldscore for pose creation [26]. In each docking run, 100 poses
were created and rescored using DrugscoreCSD [27]. The best
scored pose was used for further analysis. If more than one protein
structure was available, the ensemble docking feature [28] was
applied to select the best combination of a protein conformation
and a particular ligand pose according to maximum fitness value.
MD Simulations
MD simulations were performed using the software package
Amber in version 10 [29]. The protonation pattern of all His
residues was checked with the Protonate3D function in MOE
2009 and assigned accordingly. Atomic charges for the ligands and
the cofactor were determined using the RESP [30] methodology at
the HF/6–31G* level in Gaussian 03 [31]. Missing force field
parameters of the ligands were determined using the PARMCHK
[32] module in AMBER according to the GAFF force field [33].
The missing force field parameters for ATP were taken from the
AMBER parameter database [34]. The correct GAFF atom and
bond types of the ligand were determined with the ANTECHAM-
BER program [32]. For the protein atoms the Parm99SB force
field of AMBER [35] was used. The missing protons were added
to the protein using the program LEaP. With this software, the
starting coordinate and topology files for the simulations were
built. Complexes were minimized with the module SANDER over
200 steps using the steepest descent algorithm and a modified
generalized Born implicit solvent model [36]. Sodium ions were
added to each of the minimized structures to obtain neutrality.
Using LEaP the complexes were then solvated with the TIP3P
solvent model [37] in a box the borders of which are at least 8.0 A˚
away from the protein, which resulted in the addition of about
25000 water molecules to the system. The system was then heated
from 100 K to 300 K in 20 ps and then cooled down again to
100 K in 5 ps in the NVT ensemble (canonical ensemble, i.e.,
constant number of particles N, constant volume V, constant
temperature T) with fixed atom positions except for water and
ions. In the following step, the system was heated in the NPT
ensemble (isothermal-isobaric ensemble, i.e., constant number of
particles N, constant pressure P, and constant temperature T) to
300 K over 25 ps without restraining forces on the atoms. Then a
10 ns production trajectory was calculated under periodic
boundary conditions, at constant pressure (1 atm) and temperature
(300 K) with the weak-coupling algorithm [38] and a time step of
2 fs. The SHAKE [39] algorithm was applied to all bonds
involving hydrogen atoms, the particle mesh Ewald method [40]
was used to treat the long range electrostatic interactions and a
8.0 A˚ cut off was applied to van der Waals interactions.
Coordinates were saved every ps and energy data every 10th
time step. The generated trajectories were all centred to the
protein, projected back to their initial solvent boxes and rms fitted
to the Ca atom positions of the first frame using the program
PTRAJ. Structural descriptors were also calculated using PTRAJ
as well as the 2D rmsd values for the 2D rmsd plots. The final plots
were created using in-house python scripts and Gnuplot.
Visualisation
Protein structures were visualised by UCSF Chimera [41]. Data
plots were created by GNUPlot (www.gnuplot.info) and python
(www.python.org) scripts.
Results and Discussion
The Trys Model Containing ADP, Mg2+ and a Gsp
Analogue
The first TryS model is based on the crystal structure of EcGspS
by Pai et al. [23] and is meant to explain the first step of T(SH)2
biosynthesis (Fig. 1). The model contains ADP, 2 Mg2+ ions and a
phosphinate analogue of Gsp (see Fig. 2C) known to inhibit GspS
as well as TryS [43]. This type of phosphorous-containing
pseudopeptides has widely been used to mimic the transition state
of peptide bond formation by ATP-dependent ligases [23,42–44]
and disclose the approximate position of the c-phosphate of ATP
and, in case of TryS, the productive binding poses of the GSH to
Figure 6. Comparison of N8-Gsp and N1-Gsp binding to LmTryS by trajectory analysis. 2D-rmsd plots of N8-Gsp (left) and N1-Gsp (right) are
shown for the respective molecular dynamics simulations of the LmTryS model containing all substrates (Gsp, GSH, ATP and two Mg2+). Each colour
point represents the rmsd between the frame conformation on the x-axis and the frame conformation on the y-axis. The analysis reveals that N8-Gsp
is essentially moving into a single stable conformation (low rmsd values at the end of the simulation), while N1-Gsp adopts several ones.
doi:10.1371/journal.pone.0056788.g006
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be phosphorylated and the Sp to be acylated. Visual inspection of
protein conformation snapshots created by molecular dynamics
simulation revealed stable conformations and positions of ADP
and both Mg2+ ions in the respective binding pocket. 2D-rmsd
plots of ADP (see Figure S2 in Supporting Information S1 section
II) showed one stable conformation over the whole trajectory with
only small movements within the binding pocket. In contrast, the
Gsp analogue exhibited two major conformations during the
simulation (see Figure S2 in Supporting Information S1 section II).
In one of the conformations, the spermidine moiety is shifted
towards the end of the trajectory (see Figs. 2A and B), whereby the
central Sp amine loses the hydrogen bond to Glu 407. This
alternate binding mode could explain why the inhibitor is less
active against TryS than against GspS [43]. Otherwise the Gsp
analogue showed only small movements within the binding site,
indicating a reasonable binding mode in the TryS model.
Collectively, this data suggests the binding modes of ATP/Mg2+,
GSH and Sp for Gsp synthesis are essentially the same for EcGspS
and LmTryS, as already proposed by Fyfe et al. [19].
However, comparison of the LmTryS model (see Fig. 3B) with
the EcGspS structure (see Fig. 3A) reveals an interesting difference
between the two enzymes that likely explains why only TryS is
capable to synthesize T(SH)2. In TryS one of the flexible loops that
were not visible in the X-ray structure (Fig. 3B: Gly250– Val262) is
much longer than in EcGspS (Fig. 3A: Gly242– Pro249). In the
TryS model, this loop appears to build an additional pocket close
to the site where the spermidine moiety of the Gsp-analogue binds.
Sequence alignment reveals that the pocket results from an
insertion of 5 residues in the TryS loop region (Fig. 3C).
Preliminary docking suggested that the pocket framed by this
flexible loop might be the binding site for the glutathionyl moiety
of Gsp required for the second step of the catalysis.
Molecular dynamics simulations further supported this possi-
bility. Fig. 4 shows the distances between residues of the flexible
loop region and residues of the ‘‘rigid’’ part of the unique TryS
pocket. The analysis shows that the pocket stayed open during the
whole simulation. The distances between residues of the flexible
loop region and Glu614 are in a range between 7.4 A˚ and 27.6 A˚.
This is particularly interesting since the loop region proved to be
very flexible indeed as expected from the crystal structure (see also
Figures S5–S7 and Table S1 in Supporting Information S1 section
III). Only the connection between this unique pocket and the Sp
binding pocket is closed at some points, the distance between
Pro625 and Phe249 having a minimum of 4.2 A˚.
The hypotheses derived from the first model are compiled in
Fig. 5. For both steps of trypanothione biosynthesis GSH binds to
the same pocket (Fig. 5, red line in lower right corner) in a way
that its glycyl carboxyl can interact with both, the c-phosphate of
ATP/Mg2+ and an amino group of Sp. The Sp binding region
(Fig. 5, green line) is connected to the additional binding pocket
Figure 7. Hydrogen bonding interactions of N8-Gsp with protein residues. The inset shows a conserved water molecule in a small pocket
near the glutathionyl moiety of Gsp. (magenta: N8-Gsp, blue: residues from flexible loop region, green: residues from rigid part of Gsp binding pocket,
orange dotted lines: hydrogen bonds). None of the arginine residues directly interacts with the substrate, but both contribute to the stabilisation of
the Gsp binding pocket: Arg222 by interacting with Glu614 and Arg613 by interacting with Ser624, Leu274 (not shown) and Glu355.
doi:10.1371/journal.pone.0056788.g007
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(magenta line), presumably destined for accommodating the
glutathionyl part of Gsp during the second step of T(SH)2
biosynthesis.
The TryS Models Containing All Substrates
Creating a model with all substrates bound based on the
LmTryS crystal structure was not possible. Docking of Gsp simply
failed, because Phe 249, which points into the middle of the
presumed Gsp pocket (see above), precluded Gsp binding.
Therefore, first an LmTryS model containing ATP/Mg2+ was
generated, as described in Methods. Then, GSH was docked into
the binding site evident from the first model and the two-substrate
model was subjected to MD simulation. Both substrates retained
their positions in their presumed binding site without any major
fluctuation, but discrete conformational changes were indicated by
the 2D-rmsd and rmsd plots (see Figure S3 in Supporting
Information S1). During the simulation, the bond between the
ribose and the a-phosphate-group of ATP underwent a confor-
mational change and a flip of the GSH carboxylate near the ATP
c-phosphate was observed.
More importantly, the putative Gsp binding pocket stays open,
as in the MD simulation of the first model, and Phe 249, which
prevented Gsp docking to the crystal structure (see above), moves
out of the binding pocket. In contrast to the LmTryS X-ray
structure, representative conformations of this two-substrate model
proved to be able to accommodate N1-Gsp and N8-Gsp at the
presumed Gsp pocket. Interestingly, however, docking of the
isomers yielded remarkable differences. The docking of N8-Gsp
creates high-scoring poses that are similar for different protein
conformations. In contrast, docking poses for N1-Gsp are highly
diverse. Moreover, the free amine of Gsp that must interact with
the activated GSH is pointing away into the protein in all docking
poses, which implies an unfavourable binding mode. Also in MD
simulations, the Gsp isomers behave differently. The N8-Gsp
gradually moves into a stable conformation in its binding pocket
(see Fig. 6 left). In contrast, the N1-Gsp moves out of the binding
pocket without reaching any stable conformation (see Fig. 6 right).
Accordingly, N8-Gsp appears to be the preferred TryS substrate.
Figure 7 shows the important hydrogen bonding interactions
between N8-Gsp and the residues from the Gsp binding site based
on the hydrogen bonding analysis (see Figure S14 and Table S2–
S3 in Supporting Information S1 section V). The carboxylate
terminus interacts with the backbone amide and the hydroxyl
group of Ser264 and with Trp363. The adjacent amine interacts
with the carboxyl group of Glu614 and the backbone carbonyl
group of Phe626. It can be assumed that these residues are
functionally important, since all but Ser264 are conserved
throughout the species L. major, L. donovani, C. fasciculata, T. cruzi
and T. brucei (see sequence alignment provided by Comini et al.
[16]) and Ser264 is replaced in some sequences by amino acids
that can also provide a side chain hydrogen bonding interaction
partner (Asn in C. fasciculata and Cys in T. brucei). Interestingly, a
conserved water molecule is observed in a small pocket nearby
(Fig. 7) that can also be found in the LmTrys X-ray structure (pdb:
2vob). The amide NH and the carbonyl group of the cysteine
residue of Gsp might form hydrogen bonds with the backbone of
Phe626. The primary amine of Gsp interacts with the carbonyl
group of Gly621, The secondary amine of the spermidine moiety
interacts with the carboxy groups of Glu407 and Glu355.
Interestingly, the amino acids of the loop region seem to be less
important for the binding of Gsp, the additional amino acids in
comparison to GspS are only essential to open the pocket for
binding. Arg613, which was shown to be essential by Comini et al.
[16], shows only a marginal interaction to Gsp. Instead, it interacts
via hydrogen bonding interactions with Leu274, Ser624 and
Glu355 and can be assumed to be important to stabilize the Sp
binding region. Similarly, Arg222 is not directly involved in Gsp
binding either, but contributes to the stabilisation of the Gsp
binding pocket by interacting with Glu614.
The Gsp binding model here presented complies with earlier
reports on T(SH)2 biosynthesis. Fairlamb et al. [45] and later
Figure 8. LmTryS model with all substrates. The model represents the last frame of the molecular dynamics simulation including ATP,
glutathione and N8-Gsp. The substrate binding regions are shown as green circles. S1: ATP binding pocket; S2: glutathione binding pocket, S3:
spermidine binding region, S3+S4: N8-glutathionylspermidine binding pocket. Substrates are shown with carbon atoms in magenta.
doi:10.1371/journal.pone.0056788.g008
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Henderson et al. [46] described that the N8-Gsp appeared to be
the preferred substrate of TryS. This could now be explained by a
more stable and productive binding mode of N8-Gsp in the Gsp
binding pocket. The model further predicts that the Gsp binding
pocket could also bind free GSH. If bound this way, GSH would
certainly prevent binding of Gsp and likely impair productive
binding of Sp, thus explaining the substrate inhibition of TryS by
high concentrations of GSH reported earlier [47].
The hydrogen bonding analysis with respect to the substrates
ATP/Mg2+ and GSH (see Figure S14 and Table S2–S3 in
Supporting Information S1 section V) shows that they essentially
interact with the protein at the reaction centre as proposed earlier
[19]. Asp330 and Glu344 interact and stabilize one Mg2+ ion,
whereas Glu344 and Asn346 interact with the other Mg2+ ion.
Both Mg2+ ions, Lys513, Lys548 interact with the ATP
phosphates. Arg328 can interact with both, the ATP c-phosphate
and the glycyl carboxylate group of GSH at the catalytic centre.
This carboxylate is further hydrogen bonded to the OH of Ser351.
Its c-glutamyl carboxylate group sustains hydrogen bonds to
Met459, Ser571 and Ser462, the c-glutamyl amide group shows a
permanent hydrogen bond to Glu408 and alternating hydrogen
bonds to Asp403 and Thr457. Reliable prediction on further
contributions of the ATP grasp loop to substrate binding can not
be made, since this loop region did not adopt a stable
conformation up to the end of the MD simulation.
The last frame of the molecular dynamics simulation containing
N8-Gsp, GSH and ATP (Fig. 8) reveals how the substrates are
ideally arranged at the reaction centre for the final step of T(SH)2
biosynthesis. The functional groups of the substrates that are
involved in the reaction are close to each other. The ATP c-
phosphate points to the carboxyl group of GSH, thus enabling the
phosphorylation of its glycine moiety. The amino group of Gsp
appears to be localized in an optimum position to accept the
glutathionyl residue from the activated GSH. The entire
biosynthesis of T(SH)2 can now be described as follows: During
the first reaction ATP (S1 pocket), GSH (S2 pocket), and
Figure 9. Structural overlay of Gsp binding pocket conformations with bound Gsp. 18 representative conformations are shown (see
supporting information II-IV; blue: flexible loop region, green: rigid backbone, grey: rigid residue, magenta: glutathionylspermidine).
doi:10.1371/journal.pone.0056788.g009
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spermidine (S3 pocket) bind. After the reaction, the product Gsp,
which is generated while bound in the S2 and S3 pockets, has to
leave these binding sites to occupy the S3 and S4 pockets in an
inverted orientation (see Fig. 8). After binding of the second GSH
molecule (S2 pocket) and new ATP (S1 pocket) T(SH)2 is then
synthesized in an analogous manner.
The sequence of partial reactions is in line with the catalytic
model derived from steady state kinetics performed with
CfTryS by Comini et al. [16] Based on this analysis a central
complex mechanism was postulated for the phosphorylation of
GSH by ATP/Mg2+, while the partial reactions with Sp or Gsp
were best described as ‘ping-pong’ or ‘enzyme substitution’
kinetics, which implies that binding of ATP/Mg2+ or GSH
occurs independently from that of Sp or Gsp. The initially
formed central complex of the enzyme with ATP/Mg2+ and
GSH or, alternatively, the enzyme with bound glutathionyl-
phosphate must be stable and different enough to behave
kinetically like a ‘substituted’ enzyme which may react with Sp
or Gsp depending on which of the third substrate is bound in
the S3 or S3 plus S4 pocket, respectively. In fact, the difference
between the substrate-free LmTryS crystal structure [19] and
the two- or three-ligand models here described strongly
suggests that occupancy of the S1 or S2 pocket modulates
the S3/S4 pocket structure for productive binding of Sp or
Gsp. Thereby, an enzyme species is generated that, although
not substituted in a strict sense, is functionally distinct from the
ground state enzyme. Inversely, the decay of the initial
complex with liberation of the c-phosphate of ATP largely
depends on the reaction with Sp or Gsp, as is evident from an
only marginal ATPase activity of TryS in the absence of the
latter substrates [16]. The question which of the catalytic steps
triggers the conformational changes that affect substrate
binding and allow product release and re-binding of the
intermediate Gsp must at present be left unanswered due to
still limited structural knowledge.
Instead, we focussed on the more practical question if the
generated models might also prove helpful for structure-guided
drug design. To this end, a known TryS inhibitor (DDD66604)
was docked into representative MD-based conformations. The
latter were based on hierarchical clustering of all Gsp binding
pocket conformations from all relevant MD simulations (see
Figures S4, S5–S7, S8–S10 and S11–S13 in Supporting
Information S1 section III). This led to 18 representative
conformations of the Gsp pocket (see Fig. 9). The inhibitor (see
Fig. 10B) had been described to inhibit TryS with an IC50 of
19 mM and to be competed out by spermidine [17], suggesting
that the inhibitor binds somewhere in or near the Sp binding
region. However, docking of this inhibitor into the original
crystal structure again proved to be impossible, since Phe249
blocked the binding position (see previous section). In contrast,
docking of the inhibitor using ensemble docking yielded a
binding pose that complies with its presumed binding in the Sp
pocket (see Fig. 10), which corroborates the usefulness of MD
to unravel binding modes. Moreover, the data characterizes
the binding pockets of Sp and Gsp, respectively, as structural
elements of TryS suitable for structure-based rational drug
design.
In conclusion, a computational analysis of LmTryS compris-
ing substrate docking and molecular dynamics substantially
complemented the crystallography based understanding of the
TryS reaction in providing likely conformations of unresolved
protein loops, defining the binding pocket for the intermediate
Gsp, and explaining the complex reaction mechanism by re-
binding this intermediate from its site of generation to another
binding pocket. Moreover, the molecular dynamics-based
conformations proved to yield more realistic ligand interaction
models than a static X-ray structure, as evidenced by
Figure 10. Putative binding mode of TryS inhibitor DDD66604 to LmTryS. A: DDD66604 (turquoise) bound to the Gsp pocket. B: Chemical
formula of DDD66604. C: Comparison of binding mode of DDD66604 (turqouise) and N1-Gsp (purple).in the Gsp binding pocket.
doi:10.1371/journal.pone.0056788.g010
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compliance with functional data. It therefore may be expected
that the new insight will be of help in the design of novel
trypanocidal drugs that are based on specific inhibition of
T(SH)2 biosynthesis.
Supporting Information
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